v3.25.2
Unaudited Consolidated Balance Sheets - USD ($)
$ in Millions
Jun. 30, 2025
Dec. 31, 2024
Current Assets    
Cash and cash equivalents $ 1,173 $ 962
Trade receivables - third party and affiliates 1,216 1,121
Non-trade receivables, net 703 493
Inventories 2,288 2,284
Other assets 295 285
Total current assets 5,675 5,145
Investments in affiliates 1,263 1,217
Property, plant and equipment (net of accumulated depreciation - 2025: $4,995; 2024: $4,562) 5,303 5,273
Operating lease right-of-use assets 388 388
Deferred income taxes 1,321 1,251
Other assets 525 555
Goodwill [1] 5,466 5,387
Intangible assets, net 3,772 3,641
Total assets 23,713 22,857
Current Liabilities    
Short-term borrowings and current installments of long-term debt - third party and affiliates 252 1,501
Trade payables - third party and affiliates 1,283 1,228
Other liabilities 1,137 1,157
Income taxes payable 95 4
Total current liabilities 2,767 3,890
Long-term debt, net of unamortized deferred financing costs 12,689 11,078
Deferred income taxes 704 925
Uncertain tax positions 226 286
Benefit obligations 411 396
Operating lease liabilities 295 294
Other liabilities 917 408
Commitments and Contingencies
Shareholders' Equity    
Common stock, $0.0001 par value, 400,000,000 shares authorized (2025: 170,914,461 issued and 109,501,876 outstanding; 2024: 170,827,196 issued and 109,327,556 outstanding) 0 0
Treasury stock, at cost (2025: 61,412,585 shares; 2024: 61,499,640 shares) (5,483) (5,486)
Additional paid-in capital 419 409
Retained earnings 11,243 11,071
Accumulated other comprehensive income (loss), net (903) (848)
Total Celanese Corporation shareholders' equity 5,276 5,146
Noncontrolling interests 428 434
Total equity 5,704 5,580
Total liabilities and equity $ 23,713 $ 22,857
[1]
(1)Includes accumulated impairment losses of $1.5 billion in the Engineered Materials segment as of June 30, 2025 and December 31, 2024.